Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
0.5190
Dollar change
+0.0190
Percentage change
3.80
%
Index- P/E- EPS (ttm)- Insider Own2.25% Shs Outstand4.35M Perf Week-0.19%
Market Cap2.26M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.25M Perf Month9.26%
Income- PEG- EPS next Q-0.62 Inst Own10.63% Short Float0.30% Perf Quarter-24.78%
Sales- P/S- EPS this Y-15.58% Inst Trans-19.60% Short Ratio0.43 Perf Half Y-41.02%
Book/sh-0.62 P/B- EPS next Y- ROA- Short Interest0.01M Perf Year-75.29%
Cash/sh1.49 P/C0.35 EPS next 5Y- ROE- 52W Range0.46 - 2.44 Perf YTD-12.83%
Dividend Est.- P/FCF- EPS past 5Y30.61% ROI- 52W High-78.73% Beta2.49
Dividend TTM- Quick Ratio4.36 Sales past 5Y0.00% Gross Margin- 52W Low12.83% ATR (14)0.03
Dividend Ex-Date- Current Ratio4.36 EPS Y/Y TTM41.57% Oper. Margin0.00% RSI (14)54.06 Volatility6.00% 7.25%
Employees33 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price70.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q132.21% Payout- Rel Volume1.57 Prev Close0.50
Sales Surprise- EPS Surprise100.21% Sales Q/Q- EarningsOct 31 BMO Avg Volume29.47K Price0.52
SMA202.79% SMA503.55% SMA200-40.51% Trades Volume46,146 Change3.80%
Mar-12-24 08:00AM
Feb-29-24 08:45AM
Feb-13-24 07:00AM
Jan-25-24 10:26AM
Jan-04-24 04:01PM
06:15AM Loading…
06:15AM
Dec-29-23 09:21AM
Dec-27-23 07:15AM
Dec-20-23 08:05AM
Dec-12-23 07:26AM
Dec-11-23 08:11AM
Nov-29-23 09:25AM
Nov-20-23 07:30AM
Nov-06-23 07:30AM
Nov-03-23 04:30PM
09:00AM Loading…
Oct-31-23 09:00AM
08:23AM
Oct-30-23 07:00AM
Oct-04-23 07:30AM
Sep-19-23 04:05PM
Sep-15-23 09:01AM
Sep-13-23 04:13PM
Sep-11-23 07:30AM
Sep-06-23 06:00AM
Aug-11-23 09:00AM
Aug-01-23 04:01PM
Jul-11-23 08:17AM
Jun-05-23 07:00AM
May-30-23 06:00AM
May-15-23 04:45PM
04:25PM Loading…
Apr-17-23 04:25PM
Mar-16-23 01:10PM
Mar-06-23 01:31PM
Mar-03-23 02:07PM
Feb-02-23 02:15PM
Jan-23-23 11:50AM
06:25AM
Jan-06-23 07:15AM
Jan-05-23 07:00AM
Dec-30-22 07:30AM
Dec-21-22 11:00AM
Dec-20-22 12:42PM
Dec-16-22 08:48AM
Dec-12-22 07:06AM
Dec-08-22 11:05AM
Dec-06-22 08:30AM
07:30AM
Nov-30-22 09:15AM
Nov-29-22 07:00AM
Nov-21-22 06:00AM
Nov-15-22 08:33AM
Nov-10-22 04:00PM
Nov-03-22 11:30AM
Nov-02-22 04:30PM
Oct-18-22 07:55AM
Oct-11-22 02:00PM
Sep-30-22 07:33AM
Sep-22-22 09:05AM
Sep-20-22 06:15AM
Sep-08-22 09:13AM
Aug-25-22 07:30AM
Aug-10-22 08:33AM
Jun-27-22 10:22AM
Jun-07-22 08:41AM
Jun-01-22 07:10AM
May-19-22 11:17AM
May-12-22 06:30AM
May-09-22 06:00AM
May-02-22 10:15AM
Apr-05-22 06:49AM
Mar-31-22 04:00PM
Mar-28-22 07:00AM
Mar-24-22 09:45AM
07:05AM
Mar-14-22 08:31AM
Feb-22-22 08:44AM
Feb-15-22 08:31AM
Feb-10-22 04:30AM
Jan-26-22 07:39AM
Jan-10-22 07:00AM
Jan-03-22 10:15AM
Dec-29-21 04:01PM
Dec-27-21 04:01PM
06:45AM
Dec-23-21 08:01PM
Dec-22-21 11:29AM
09:09AM
09:00AM
07:07AM
Nov-30-21 07:05AM
Nov-24-21 01:46PM
Nov-15-21 05:15AM
Oct-19-21 07:30AM
Sep-15-21 08:59AM
Aug-26-21 04:05PM
Jun-23-21 06:00AM
Jun-15-21 03:23PM
May-13-21 04:54PM
Mar-23-21 07:44AM
Feb-10-21 04:30PM
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.